Processa Pharmaceuticals, Inc. PCSA
1.56 USD -0.13 (-7.69%)
Regular-session close
1.59 +0.03 +1.92%
After hours · Nov 20, 4:00 PM ET
1.39 Day range 1.66
1.04 52-week range 8.88
- YTD
- -45.83%
- 1 year
- -77.13%
Discussion (27)
I will buy sooner
I will buy under $3
It’s clearly done. It’ll finish in the 5’s
$PCSA - can we see more info on this Breast Cancer Ph.2 this week?
The NGC-Cap (PCS6422) Phase 2 trial will likely produce its first meaningful data soon.
$PCSA Nope still mooving but slowly
$PCSA Slowly but steady…
Data today!!!
$PCSA CANT WAIT FOR MONDAYYY!!!
